Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07466342) titled 'Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women' on March 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Nishtar Medical University
Condition:
Dysmenorrhea Primary
Vitamin E
Mefenamic Acid
Intervention:
Drug: Mefenamic acid
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: July 15, 2025
Target Sample Size: 60
Countries of Recruitment:
Pakistan
To know more, visit https://clinicaltr...